Zobrazeno 1 - 7
of 7
pro vyhledávání: '"L D, Altstiel"'
Autor:
E. J. Holsztynska, K. L. Sacchi, L. Z. Chen, J. C. Clemens, I. M. Lieberburg, L. C. Mutter, Bruce D. Gitter, T. C. Britton, C. A. Whitesitt, E. D. Thorsett, L. D. Altstiel, M. H. Bender, K. L. Johnson-Wood, G. M. Shopp, R. N. Motter, B. Folmer, T. E. Mabry, D. Stephenson, S. Yang, B. D. Potts, Binhui Ni, D. B. Schenk, T. Yin, Paul A. Hyslop, Jon K. Reel, K. L. Hu, W.-Y. Li, C. T. Yin, J. E. Knops, P. De Saint Andrieu, V. John, Z. Liao, E. Goldbach, F. D. Miller, L. A. Shipley, J. Wu, E. M. Johnstone, L. H. Latimer, S. B. Freedman, J. P. Anderson, H. F. Dovey, P. A. Seubert, Michael K. Lee, D. K. Dieckman-Mcginty, S. L. Kennedy, J. S. Nissen, Sheila P. Little, Leonard N. Boggs, J. S. Tung, J. Nietz, L. Y. Fang, D. L. Czilli, Patrick C. May, Warren J. Porter, James E. Audia, K. P. Quinn, J. J. Droste, D. Kholodenko, Y. Su, Kimberly S. Fuson
Publikováno v:
Journal of Neurochemistry. 76:173-181
Converging lines of evidence implicate the beta-amyloid peptide (Ass) as causative in Alzheimer's disease. We describe a novel class of compounds that reduce A beta production by functionally inhibiting gamma-secretase, the activity responsible for t
Autor:
L. D. Altstiel
Publikováno v:
Alzheimer disease and associated disorders. 16
The major barrier to Alzheimer disease (AD) drug discovery and development in the biotechnology industry is scale. Most biotechnology companies do not have the personnel or expertise to carry a drug from the bench to the market. Much effort in the in
Autor:
H F, Dovey, V, John, J P, Anderson, L Z, Chen, P, de Saint Andrieu, L Y, Fang, S B, Freedman, B, Folmer, E, Goldbach, E J, Holsztynska, K L, Hu, K L, Johnson-Wood, S L, Kennedy, D, Kholodenko, J E, Knops, L H, Latimer, M, Lee, Z, Liao, I M, Lieberburg, R N, Motter, L C, Mutter, J, Nietz, K P, Quinn, K L, Sacchi, P A, Seubert, G M, Shopp, E D, Thorsett, J S, Tung, J, Wu, S, Yang, C T, Yin, D B, Schenk, P C, May, L D, Altstiel, M H, Bender, L N, Boggs, T C, Britton, J C, Clemens, D L, Czilli, D K, Dieckman-McGinty, J J, Droste, K S, Fuson, B D, Gitter, P A, Hyslop, E M, Johnstone, W Y, Li, S P, Little, T E, Mabry, F D, Miller, J E, Audia
Publikováno v:
Journal of neurochemistry. 76(1)
Converging lines of evidence implicate the beta-amyloid peptide (Ass) as causative in Alzheimer's disease. We describe a novel class of compounds that reduce A beta production by functionally inhibiting gamma-secretase, the activity responsible for t
Autor:
J M, Silverman, D A, Greenberg, L D, Altstiel, L J, Siever, R C, Mohs, C J, Smith, G, Zhou, T E, Hollander, X P, Yang, M, Kedache, G, Li, M L, Zaccario, K L, Davis
Publikováno v:
American journal of medical genetics. 67(2)
We attempted to identify a locus for schizophrenia and related disorders in 24 nuclear families of schizophrenic probands using a predefined classification system for affected cases that included those disorders most clearly identified as sharing a g
Autor:
G, Li, J M, Silverman, L D, Altstiel, V, Haroutunian, D P, Perl, D, Purohit, S, Birstein, M, Lantz, R C, Mohs, K L, Davis
Publikováno v:
Genetic epidemiology. 13(3)
Recent studies have found an association between presence of apolipoprotein E (APOE) epsilon 4 allele and Alzheimer's disease (AD). The present study compared the cumulative risk of primary progressive dementia (PPD) in relatives of AD probands carry
Publikováno v:
Dementia (Basel, Switzerland). 6(1)
A portion of Alzheimer's disease (AD) patients have elevated serum levels of the acute phase reactant alpha 1-antichymotrypsin (A1ACT) compared to age-matched controls. We measured serum levels of A1ACT in AD patients, age-matched controls, Down's sy
Autor:
F R Landsberger, L D Altstiel
Publikováno v:
Journal of virology. 39(1)
Spin label electron spin resonance techniques using a nitroxide derivative of stearic acid were used to detect changes in plasma membrane structure caused by the binding of vesicular stomatitis virus (VSV) to cell plasma membranes of intact BHK-21 ce